Mitesco, INC

Mitesco, Inc. announced $225,000 in bridge financing and a non-binding term sheet for a $30 million Equity Line of Credit, alongside the launch of its AI real estate platform, RoboAgent.

Mitesco, Inc. has entered into a $50,000 bridge financing agreement and issued additional Series X Preferred Stock to directors and a consultant.

Mitesco, Inc. has entered into a $50,000 bridge financing agreement and issued shares for Series X dividend payments and Series A preferred stock redemptions.

Mitesco, Inc. announced key executive appointments and outlined its strategy for growth through data center expansion and software acquisitions.

Mitesco, Inc. announced an additional $125,000 in funding through a Senior Secured 10% Original Issue Discount Convertible Promissory Note, bringing total recent funding to $625,000 under these terms.

Mitesco, Inc. announced its AI-powered RoboAgent platform prototype is ready for live demonstration, marking a key product development milestone.

Mitesco Inc. reports zero revenue for Q1 2026, shifting focus to data center services and AI development, while facing ongoing liquidity concerns and significant liabilities.

Mitesco, Inc. reported a significant net loss in Q3 2025 and faces substantial doubt about its ability to continue as a going concern, despite new ventures in data centers and AI.

Mitesco, Inc. reported a net income for Q2 2025 driven by non-operating gains from debt restructuring and derivative revaluation, despite ongoing operational losses and significant going concern doubts.

Mitesco, Inc. reports a net income of $3.45 million for Q1 2025, driven by gains on revaluation of derivative liabilities, while initiating revenue generation from its newly formed subsidiaries.

Mitesco Inc. reports a net income of $2.05 million for the third quarter of 2024, driven by gains on debt and accounts payable settlements, and the launch of its new data center services business.

Mitesco Inc. reported a net loss of $365,921 for the six months ended June 30, 2024, and is transitioning from healthcare clinics to data center services.

Mitesco, Inc. reports a strategic pivot towards data center services and AI applications, while continuing debt restructuring efforts and addressing internal control weaknesses.

Mitesco, Inc. files its 10-K report for the year ended December 31, 2024, highlighting a strategic shift towards data center services and AI development while managing significant debt through restructuring.

Mitesco Inc. discontinues its clinic operations and pivots towards acquiring healthcare technology and service businesses, while addressing significant financial challenges.

Mitesco CEO Mack Rimmer Leath Jr. acquired 8,787 shares of common stock at $0.18 per share, increasing his beneficial ownership to 394,327 shares.

Mitesco, Inc. CEO Mack Rimmer Leath Jr. acquired 4,063 shares of common stock at $0.37 per share, increasing his beneficial ownership.

Mitesco Inc. Director Jordan Paul Balencic has reported a pre-planned acquisition of 4,063 shares of common stock at $0.3733 per share, effective June 30, 2025.

Mitesco CEO Mack Rimmer Jr. reports acquiring common stock through transactions on April 24, 2025.

Director Jordan Paul Balencic reports acquiring Mitesco, Inc. (MITI) common stock through two transactions on April 24, 2025.

Director John Gormer Jr. reports acquiring additional shares of Mitesco, Inc. at prices of $0.44 and $0.59.

Mitesco, Inc. has filed an S-1/A registration statement to allow for the resale of up to 106,548,245 shares of common stock by selling stockholders.

Mitesco, Inc. has filed a Form S-1 registration statement to allow selling stockholders to resell up to 106,548,245 shares of common stock.

Mitesco, Inc. files an S-1 registration for the resale of over 106 million common shares, highlighting a strategic pivot to data center and AI services following the closure of its unprofitable clinic operations, amidst significant debt restructuring and ongoing going concern doubts.

Mitesco, Inc. is undergoing a significant business model transformation, pivoting from unprofitable medical clinics to data center services and AI software development, while grappling with substantial debt and a going concern warning.

Mitesco, Inc. is filing an amendment to its registration statement for the potential resale of up to 15,278,771 shares of common stock by selling stockholders.

Mitesco, Inc. is filing an amendment to its S-1 registration statement to allow selling stockholders to resell up to 15,278,771 shares of common stock.

Anglo Irish Management, LLC, led by Daniel Hollis, has reported a beneficial ownership of 44.98% of MITESCO, INC.'s voting power, primarily for investment purposes.

Mack Leath, a director and officer of Mitesco, Inc., has filed a Schedule 13D disclosing a 7.05% beneficial ownership stake, primarily acquired through debt settlement and compensation for services, following the company's default on a promissory note.

Dr. Jordan Balencic, a director of Mitesco, Inc., has disclosed a 6.41% beneficial ownership stake in the company, primarily acquired through compensation for director and non-director services.

Anglo Irish Management, LLC, managed by Daniel Hollis, has disclosed a significant 27.19% beneficial ownership stake in Mitesco, Inc., primarily for investment purposes.

John Mitchell, a director of Mitesco, Inc., has increased his beneficial ownership in the company to 6.64% through a series of transactions including open market purchases, settlement of a promissory note, and compensation for services.

Anglo Irish Management, LLC has disclosed a beneficial ownership of 29.26% of Mitesco, Inc.'s common stock, primarily for investment purposes, through a combination of common and high-voting preferred shares.